ENDONOVO THERAPEUTICS, INC. (ENDV) Gross profit 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) annual gross profit history from SEC filings — each fiscal year as reported.
$125,365FY2022 · since FY2013: $8,903 → $125,365
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $125,365 | +115.7% |
| FY2021 | $58,120 | -42.1% |
| FY2020 | $100,427 | -53.7% |
| FY2019 | $216,779 | +208.2% |
| FY2018 | $70,333 | — |
| FY2015 | $2,103 | -75.8% |
| FY2014 | $8,707 | -2.2% |
| FY2013 | $8,903 | — |
Source: SEC XBRL filings · For reference only · Not investment advice